Results of complex treatment of patients with locally advanced squamous cell carcinoma of the paranasal sinuses and nasal cavity using induction chemotherapy

Introduction. About 600 new cases of malignant neoplasms of the paranasal sinuses and nasal cavity are detected annually in Russia. To date, there are no randomized trials to determine the optimal treatment algorithm for this group of patients. Data on the use of induction chemotherapy in squamous cell carcinoma of sino-nasal tract are limited to a small series of clinical observations and, often, are retrospective in nature.

Aim. Evaluation of the effectiveness of induction chemotherapy in patients with locally advanced squamous cell carcinoma of the paranasal sinuses and nasal cavity.

Materials and methods. Since 2012, 22 patients with locally advanced cancer of the paranasal sinuses and nasal cavity have been treated in our center, who underwent 3-component induction chemotherapy according to the TPF protocol. Evaluation of the effectiveness of treatment was carried out according to the criteria of Response evaluation criteria in solid tumors 1.1 (RECIST 1.1). Patients with a decrease in the tumor size by 30 % or more, were followed by radiation therapy in doses of 66–70 Gy. Patients with a residual tumor underwent surgery after the end of chemoradiotherapy.

Results. In 21 patients available for analysis, overall response rate after induction chemotherapy was 71 %: complete response was registered in 3 (14 %) patients, partial response in 12 (57 %), stable disease in 4 (19 %). Progression disease after 3 courses of induction chemotherapy was detected in 2 (10 %) patients.

Conclusions. Thus, induction chemotherapy in patients with squamous cell carcinoma of sino-nasal tractseems to be a promising direction for investigation, that can significantly improve the long-term results of treatment of this category of patients and help to avoid of disabling surgery in some of them.

1. Ansa B., Goodman M., Ward K. et al. Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer 2013;119(14):2602–10. DOI: 10.1002/cncr.28108

2. Malignant diseases in Russia in 2018 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “NMIC of Radiology”, Ministry of Health of Russia, 2019. P. 11. (In Russ.).

3. Thompson L.D.R. Sinonasal carcinomas. Curr Diagn Pathol 2006;12:40–53.

4. Dulguerov P., Allal A.S. Nasal and paranasal sinus carcinoma: how can we continue to make progress? Curr Opin Otolaryngol Head Neck Surg 2006;14(2):67–72. DOI: 10.1097/01.moo.0000193177.62074.fd

5. Olshansky V.O., Reshetov I.V., Sdvizhkov A.M., Cherekaev V.A. Treatment of common malignant tumors of the nose, paranasal sinuses and upper jaw. Rossijskij onkologicheskij zhurnal = Russian Journal of Oncology 1998;3:63–6. (In Russ.).

6. Clinical recommendations “Cancer of the nasal cavity and paranasal sinuses”. 2020. (In Russ.). Available at: https://oncology-association.ru/wp-content/uploads/2020/09/rak_polosti_nosa.pdf.

7. NCCN Guidelines Version 3.2021. Head and neck cancers. Available at: https://www.nccn.org/login?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

8. Licitra L., Locati L.D., Cavina R. et al Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Ann Oncol 2003;14(3):367–72. DOI: 10.1093/annonc/mdg113

9. Hanna E.Y., Cardenas A.D., DeMonte F. et al. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 2011;137(1):78–81. DOI: 10.1001/archoto.2010.231

10. Kang J.H., Cho S.H., Kim J.P. et al. Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis. J Oral Maxillofac Surg 2012;70(7):1717–23. DOI: 10.1016/j.joms.2011.06.221

11. Won H.S., Chun S.H., Kim B.S. et al. Treatment outcome of maxillary sinus cancer. Rare tumors 2009;1(2):e36. DOI: 10.4081/rt.2009.e36

12. Noronha V., Patil V.M., Joshi A. et al. Induction chemotherapy in technically unresectable locally advanced carcinoma of maxillary sinus. Chemother Res Pract 2014;2014:487872. DOI: 10.1155/2014/487872

13. Dulguerov P., Jacobsen M.S., Allal A.S. et al. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001;92(12):3012–29. DOI: 10.1002/1097-0142(20011215)92:12<3012::aid-cncr10131>3.0.co;2-e